Richard A. Paulson insider trades: Karyopharm Therapeutics (KPTI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
41 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | KPTI | ↓ Sell | 2,203 | $9.50 | $21K | Direct | May 15, 2026 (1d) |
| Sep 15, 2025 | KPTI | ↓ Sell | 1,257 | $6.43 | $8K | Direct | Sep 16, 2025 (1d) |
| May 6, 2025 | KPTI | ↓ Sell | 236 | $7.12 | $2K | Direct | May 7, 2025 (1d) |
| Apr 4, 2025 | KPTI | ↓ Sell | 245 | $3.74 | $916 | Direct | Apr 7, 2025 (3d) |
| Mar 4, 2025 | KPTI | ↓ Sell | 11,694 | $6.29 | $74K | Direct | Mar 6, 2025 (2d) |
| Feb 4, 2025 | KPTI | ↓ Sell | 4,099 | $0.65 | $3K | Direct | Feb 5, 2025 (1d) |
| Jan 6, 2025 | KPTI | ↓ Sell | 4,055 | $0.78 | $3K | Direct | Jan 7, 2025 (1d) |
| Dec 4, 2024 | KPTI | ↓ Sell | 3,620 | $0.81 | $3K | Direct | Dec 5, 2024 (1d) |
| Nov 5, 2024 | KPTI | ↓ Sell | 3,675 | $0.91 | $3K | Direct | Nov 6, 2024 (1d) |
| Oct 4, 2024 | KPTI | ↓ Sell | 3,607 | $0.88 | $3K | Direct | Oct 7, 2024 (3d) |
| Sep 4, 2024 | KPTI | ↓ Sell | 3,667 | $0.72 | $3K | Direct | Sep 5, 2024 (1d) |
| Aug 6, 2024 | KPTI | ↓ Sell | 3,608 | $0.93 | $3K | Direct | Aug 8, 2024 (2d) |
| Jul 5, 2024 | KPTI | ↓ Sell | 3,616 | $0.85 | $3K | Direct | Jul 9, 2024 (4d) |
| Jun 4, 2024 | KPTI | ↓ Sell | 3,592 | $0.99 | $4K | Direct | Jun 6, 2024 (2d) |
| May 6, 2024 | KPTI | ↓ Sell | 3,576 | $1.13 | $4K | Direct | May 7, 2024 (1d) |
| Apr 4, 2024 | KPTI | ↓ Sell | 3,563 | $1.29 | $5K | Direct | Apr 5, 2024 (1d) |
| Mar 5, 2024 | KPTI | ↓ Sell | 3,573 | $1.30 | $5K | Direct | Mar 6, 2024 (1d) |
| Mar 1, 2024 | KPTI | ↓ Sell | 99,844 | $1.18 | $117K | Direct | Mar 4, 2024 (3d) |
| Feb 6, 2024 | KPTI | ↓ Sell | 4,012 | $1.59 | $6K | Direct | Feb 8, 2024 (2d) |
| Jan 4, 2024 | KPTI | ↓ Sell | 4,114 | $0.82 | $3K | Direct | Jan 8, 2024 (4d) |
| Dec 4, 2023 | KPTI | ↓ Sell | 3,622 | $0.79 | $3K | Direct | Dec 5, 2023 (1d) |
| Nov 6, 2023 | KPTI | ↓ Sell | 3,606 | $0.92 | $3K | Direct | Nov 7, 2023 (1d) |
| Oct 4, 2023 | KPTI | ↓ Sell | 3,589 | $1.27 | $5K | Direct | Oct 5, 2023 (1d) |
| Sep 5, 2023 | KPTI | ↓ Sell | 3,622 | $1.33 | $5K | Direct | Sep 6, 2023 (1d) |
| Aug 7, 2023 | KPTI | ↓ Sell | 3,722 | $1.72 | $6K | Direct | Aug 8, 2023 (1d) |
| Jul 5, 2023 | KPTI | ↓ Sell | 3,538 | $1.72 | $6K | Direct | Jul 6, 2023 (1d) |
| Jun 5, 2023 | KPTI | ↓ Sell | 3,536 | $2.24 | $8K | Direct | Jun 7, 2023 (2d) |
| May 4, 2023 | KPTI | ↓ Sell | 3,805 | $3.35 | $13K | Direct | May 5, 2023 (1d) |
| Apr 4, 2023 | KPTI | ↓ Sell | 3,497 | $3.97 | $14K | Direct | Apr 5, 2023 (1d) |
| Mar 6, 2023 | KPTI | ↓ Sell | 3,506 | $3.16 | $11K | Direct | Mar 7, 2023 (1d) |
| Mar 1, 2023 | KPTI | ↓ Sell | 33,033 | $3.03 | $100K | Direct | Mar 2, 2023 (1d) |
| Feb 6, 2023 | KPTI | ↓ Sell | 3,950 | $3.40 | $13K | Direct | Feb 8, 2023 (2d) |
| Jan 4, 2023 | KPTI | ↓ Sell | 3,922 | $3.27 | $13K | Direct | Jan 5, 2023 (1d) |
| Dec 5, 2022 | KPTI | ↓ Sell | 3,490 | $5.17 | $18K | Direct | Dec 6, 2022 (1d) |
| Nov 4, 2022 | KPTI | ↓ Sell | 3,493 | $4.54 | $16K | Direct | Nov 8, 2022 (4d) |
| Oct 4, 2022 | KPTI | ↓ Sell | 3,488 | $5.87 | $20K | Direct | Oct 5, 2022 (1d) |
| Sep 8, 2022 | KPTI | ↓ Sell | 3,479 | $5.23 | $18K | Direct | Sep 9, 2022 (1d) |
| Aug 4, 2022 | KPTI | ↓ Sell | 2,314 | $4.48 | $10K | Direct | Aug 5, 2022 (1d) |
| Jul 8, 2022 | KPTI | ↓ Sell | 2,115 | $5.18 | $11K | Direct | Jul 11, 2022 (3d) |
| Jun 7, 2022 | KPTI | ↓ Sell | 2,542 | $5.76 | $15K | Direct | Jun 8, 2022 (1d) |
| May 4, 2022 | KPTI | ↓ Sell | 28,502 | $6.23 | $178K | Direct | May 5, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KPTI insiders
Open-market trades in the last 12 months
About Richard A. Paulson's insider trades
Richard A. Paulson is President and CEO at Karyopharm Therapeutics (KPTI). Since May 4, 2022, Richard has reported no open-market purchases and 41 sales worth $760K on SEC Form 4. In the last 12 months: 1 sale ($21K).
Their filings also include grants and awards (14 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KPTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.